Toronto-based Cedara Software, a Merge Healthcare company and an independent developer of medical software technologies for the global healthcare market, has announced a strategic partnership with Medical Imaging Applications LLC (MIA) of Coralville, Iowa. As part of the agreement, Cedara will distribute MIA’s vascular software applications to OEM companies through its global distribution network on an exclusive basis. MIA will focus on clinical development and continuing advancement of its toolset.

AngioDynamics, Inc. has announced FDA 510(k) clearance for Oncobionic, Inc. to market Irreversible Electroporation (IRE) — a technology approved for the surgical ablation of soft tissue, including cardiac and smooth muscle.

AngioDynamic’s acquisition of Oncobionic for a total of $25 million will be completed following successful human use of its IRE technology, testing that is expected to begin mid-year 2007.

Two novel polymer-free drug-eluting stent coating technologies tested in a comparative animal study has concluded with positive results, according to a release from Atlanta-based MIV Therapeutics.

Possis Medical, Inc. has received clearance from the FDA to market its AngioJet Xpeedior catheter to remove blood clots (thrombus) from upper- and lower-extremity peripheral veins. Used with the company’s AngioJet System, Xpeedior is the only device cleared for thrombectomy in peripheral veins.

Magnets may interfere with the operation of pacemakers and implantable cardioverter defibrillators (ICDs), according to a study published in the December 2006 edition of “Heart Rhythm.”

The Third International Conference on Cell Therapy for Cardiovascular Diseases will convene Jan 17 to 19, at The New York Academy of Medicine in New York, NY. The three-day program is dedicated to the evolving field of cell-based therapies for cardiac repair and regeneration.

The FDA has cleared Toshiba's new EXCELART Vantage Atlas 1.5T MRI system, which the company showcased this week during the annual meeting and exhibit of the Radiological Society of North America in Chicago.

GE Healthcare has launched its new LightSpeed VCT XT, the industry’s first CT scanner that maintains outstanding image quality while reducing a patient’s radiation exposure by up to 70 percent for diagnostic cardiac scans. The company unveiled the technology this week during the annual meeting of the Radiological Society of North America in Chicago.

An innovative lead insulation material for cardiac leads used with pacemakers and ICDs is now FDA approved and available in the U.S. Optim, from St. Jude Medical, is the first silicone-polyurethane co-polymer material created specifically for cardiac lead use.

An implantable technology to control high blood pressure in patients not responding to available medicines has demonstrated initial favorable results in a study conducted at the University Hospital Berne in Switzerland. Developed by Minneapolis-based CVRx in 2002 and entering a clinical trial in the U.S., the tiny device - called the Rheos system - was first implanted in 11 patients undergoing surgery for carotid stenosis. Dr. Jurg Schmidli and colleagues placed electrodes outside the carotid wall and applied electrical stimulation.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now